✦ LIBER ✦

A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group)

✍ Scribed by M. Shiraki; M. Fukunaga; K. Kushida; H. Kishimoto; Y. Taketani; H. Minaguchi; T. Inoue; R. Morita; H. Morii; K. Yamamoto; Y. Ohashi; H. Orimo

Book ID: 105863150
Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 320 KB
Volume: 14
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-002-1369-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-Weekly Risedronate in Men With Oste

Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study

✍ Steven Boonen; Eric S Orwoll; Dietrich Wenderoth; Karen J Stoner; Rachelle Euseb 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 479 KB

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National

A comparison of incidences of vertebral

A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial

✍ Kazuhiro Kushida; Masao Fukunaga; Hideaki Kishimoto; Masataka Shiraki; Akira Ita 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 974 KB

Ipilimumab monotherapy in patients with

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

✍ Jedd D Wolchok; Bart Neyns; Gerald Linette; Sylvie Negrier; Jose Lutzky; Luc Tho 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 246 KB

A randomized, double-blind dose-ranging

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD

✍ James F. Donohue; Antonio Anzueto; Jean Brooks; Rashmi Mehta; Christopher Kalber 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 989 KB

Efficacy and Safety of the Selective Ald

Efficacy and Safety of the Selective Aldosterone Blocker Eplerenone in Japanese Patients With Hypertension: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

✍ Takao Saruta; Shigeru Kageyama; Toshio Ogihara; Kunio Hiwada; Masayo Ogawa; Kazu 📂 Article 📅 2004 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 322 KB